Xlife Sciences AG
SIX:XLS

Watchlist Manager
Xlife Sciences AG Logo
Xlife Sciences AG
SIX:XLS
Watchlist
Price: 21.8 CHF -14.17% Market Closed
Market Cap: 125.8m CHF

Net Margin
Xlife Sciences AG

3 663.7%
Current
2 869%
Average
1%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
3 663.7%
=
Net Income
30.8m
/
Revenue
839.4k

Net Margin Across Competitors

No Stocks Found

Xlife Sciences AG
Glance View

Xlife Sciences AG focuses on the value development of performance promising technologies in life sciences. The company is headquartered in Zurich, Zuerich and currently employs 19 full-time employees. The company went IPO on 2019-09-30. The firm focuses on investing in technologies in the life science industry. The company supports researchers and entrepreneurs in positioning, structuring, developing and implementing their concepts. The firm offers its investors direct access to the further development of technologies at a very early stage. The firm cooperates with industrial partners and universities.

XLS Intrinsic Value
HIDDEN
Show
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
3 663.7%
=
Net Income
30.8m
/
Revenue
839.4k
What is the Net Margin of Xlife Sciences AG?

Based on Xlife Sciences AG's most recent financial statements, the company has Net Margin of 3 663.7%.

Back to Top